BRCA2 and breast cancer: In response to recent studies reporting that an individual’s PRS may modify the penetrance of rare PVs in the BRCA1 and BRCA2 genes [9,10,32,35], we sought evidence of risk modification by the PRS in PV carriers affected and unaffected by prevalent BC in our study.